+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Could first- and second-trimester biochemical markers for Down syndrome have a role in predicting intrahepatic cholestasis of pregnancy?



Could first- and second-trimester biochemical markers for Down syndrome have a role in predicting intrahepatic cholestasis of pregnancy?



Archives of Medical Science 14(4): 846-850



The aim of this study is to compare first- and second-trimester Down syndrome biochemical screening markers in intrahepatic cholestasis of pregnancy (ICP) and normal pregnancies. This observational case-control study was conducted at Health Sciences University Zeynep Kamil Maternity and Children's Health Training and Research Hospital and the Department of Obstetrics and Gynecology at Erciyes University Medical Faculty during 2016-2017. The study included 165 patients, and consisted of 62 women who had been diagnosed with ICP (the ICP-diagnosed group) and 103 healthy pregnant women (the control group). First-trimester free β-human chorionic gonadotropin (β-hCG), pregnancy-associated plasma protein-A (PAPP-A) and second-trimester total β-hCG, estriol (E3), α-fetoprotein (AFP), and inhibin A levels were compared between the two groups. The mean patient age was 28.67 ±5.96 years, with no significant difference between the groups (p > 0.05). Average PAPP-A levels were significantly lower in the ICP-diagnosed group (p < 0.001). When the cut-off value for PAPP-A was taken as ≤ 0.93 multiple of median (MoM), the sensitivity and specificity values for ICP were 73.8% and 56.3%, respectively (95% CI, AUC ± SE: 0.663 ±0.042). The decrease in PAPP-A MoM value indicates an increase in the risk of developing ICP, while changes in other markers were not sufficient to predict ICP.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057117247

Download citation: RISBibTeXText

PMID: 30002703

DOI: 10.5114/aoms.2017.69865


Related references

Predicting respiratory distress syndrome in neonates from mothers with intrahepatic cholestasis of pregnancy. Early Human Development 84(5): 337-341, 2008

Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 393(10174): 899-909, 2019

First trimester maternal serum PAPP-A levels and associated pregnancy complications in intrahepatic cholestasis of pregnancy. Clinical and Experimental Obstetrics and Gynecology 43(5): 673-677, 2016

NR1H4 analysis in patients with progressive familial intrahepatic cholestasis, drug-induced cholestasis or intrahepatic cholestasis of pregnancy unrelated to ATP8B1, ABCB11 and ABCB4 mutations. Clinics and Research in Hepatology and Gastroenterology 36(6): 569-573, 2012

Spontaneous hemoperitoneum with intrahepatic cholestasis during the third trimester of pregnancy. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 127(3): 297-298, 2014

Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy. Best Practice and Research. Clinical Gastroenterology 24(5): 541-553, 2010

Intrahepatic cholestasis of pregnancy has no effect on maternal serum second trimester alpha-fetoprotein and hCG. Acta Obstetricia et Gynecologica Scandinavica 79(7): 548-552, 2000

The influence of maternal opiate use in pregnancy on second trimester biochemical markers for Down syndrome. Prenatal Diagnosis 29(9): 863-865, 2009

MiR-148a-mediated estrogen-induced cholestasis in intrahepatic cholestasis of pregnancy: Role of PXR/MRP3. Plos one 12(6): E0178702, 2017

Severe First Trimester Recurrent Intrahepatic Cholestasis of Pregnancy: A Case Report and Literature Review. Ajp Reports 6(1): E38-E41, 2016

Predicting fetal asphyxia in intrahepatic cholestasis of pregnancy. Archives of Gynecology and Obstetrics 280(6): 975-979, 2009

Clinical, biochemical peculiarities and outcome of pregnancy of patients with intrahepatic cholestasis of pregnancy treated with ursodeoxycholic acid. Journal of Hepatology 36(Suppl. 1): 252, 2002

Study on relationship between expression of familial intrahepatic cholestasis 1 mRNA in placenta and Intrahepatic cholestasis of pregnancy. Sichuan Da Xue Xue Bao. Yi Xue Ban 39(3): 430-433, 2008

Familial benign recurrent intrahepatic cholestasis. Interrelation with intrahepatic cholestasis of pregnancy and from oral contraceptives?. Gastroenterology 71(2): 202-207, 1976

Biochemical parameters of the intrahepatic cholestasis of pregnancy. Ceska Gynekologie 72(2): 90-94, 2007